365 related articles for article (PubMed ID: 33754209)
1. Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review.
Lim SN; Wu T; Tseng WJ; Chiang HI; Cheng MY; Lin WR; Lin CN
J Neurol; 2021 Oct; 268(10):3744-3757. PubMed ID: 33754209
[TBL] [Abstract][Full Text] [Related]
2. Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain.
Strzelczyk A; Knake S; Kälviäinen R; Santamarina E; Toledo M; Willig S; Rohracher A; Trinka E; Rosenow F
Acta Neurol Scand; 2019 Apr; 139(4):369-376. PubMed ID: 30613951
[TBL] [Abstract][Full Text] [Related]
3. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit.
Rohracher A; Höfler J; Kalss G; Leitinger M; Kuchukhidze G; Deak I; Dobesberger J; Novak H; Pilz G; Zerbs A; Trinka E
Epilepsy Behav; 2015 Aug; 49():354-8. PubMed ID: 25962657
[TBL] [Abstract][Full Text] [Related]
4. Use of perampanel oral suspension for the treatment of refractory and super-refractory status epilepticus.
Bruschi G; Pellegrino L; Bisogno AL; Ferreri F; Kassabian B; Seppi D; Favaretto S; Corbetta M; Dainese F
Epilepsy Behav; 2024 Jul; 156():109826. PubMed ID: 38761446
[TBL] [Abstract][Full Text] [Related]
5. Perampanel Treatment for Refractory Status Epilepticus in a Neurological Intensive Care Unit.
Ho CJ; Lin CH; Lu YT; Shih FY; Hsu CW; Tsai WC; Tsai MH
Neurocrit Care; 2019 Aug; 31(1):24-29. PubMed ID: 30891695
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
[TBL] [Abstract][Full Text] [Related]
7. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit: A single-center audit of 30 patients.
Rohracher A; Kalss G; Neuray C; Höfler J; Dobesberger J; Kuchukhidze G; Kreidenhuber R; Florea C; Thomschewski A; Novak HF; Pilz G; Leitinger M; Trinka E
Epilepsia; 2018 Oct; 59 Suppl 2():234-242. PubMed ID: 30043411
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of perampanel oral loading in postanoxic super-refractory status epilepticus: A pilot study.
Beretta S; Padovano G; Stabile A; Coppo A; Bogliun G; Avalli L; Ferrarese C
Epilepsia; 2018 Oct; 59 Suppl 2():243-248. PubMed ID: 30159874
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with occurrence and outcome of super-refractory status epilepticus.
Madžar D; Knappe RU; Reindl C; Giede-Jeppe A; Sprügel MI; Beuscher V; Gollwitzer S; Hamer HM; Huttner HB
Seizure; 2017 Nov; 52():53-59. PubMed ID: 28963934
[TBL] [Abstract][Full Text] [Related]
10. A retrospective, observational study of perampanel in refractory and super-refractory status epilepticus.
Alsherbini K; Abhi Pandhi F; Goyanes J; Deep A; Jones GM
J Neurol Sci; 2020 Dec; 419():117214. PubMed ID: 33161303
[TBL] [Abstract][Full Text] [Related]
11. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study.
Delaj L; Novy J; Ryvlin P; Marchi NA; Rossetti AO
Acta Neurol Scand; 2017 Jan; 135(1):92-99. PubMed ID: 27080243
[TBL] [Abstract][Full Text] [Related]
12. Perampanel in achieving status epilepticus cessation: A systematic review.
Perez DQ; Espiritu AI; Jamora RDG
Epilepsy Behav; 2022 Mar; 128():108583. PubMed ID: 35151187
[TBL] [Abstract][Full Text] [Related]
13. Determinants and predictors of outcome in super refractory status epilepticus--a developing country perspective.
Jayalakshmi S; Ruikar D; Vooturi S; Alladi S; Sahu S; Kaul S; Mohandas S
Epilepsy Res; 2014 Nov; 108(9):1609-17. PubMed ID: 25246354
[TBL] [Abstract][Full Text] [Related]
14. Specific characteristics and current diagnostic and treatment modalities performance of super refractory status epilepticus in children: A comparative study.
Briassoulis G; Stefanogianni C; Zaganas I; Raissaki M; Briassoulis P; Ilia S
Eur J Paediatr Neurol; 2022 Mar; 37():32-39. PubMed ID: 35051734
[TBL] [Abstract][Full Text] [Related]
15. Vagus nerve stimulation in refractory and super-refractory status epilepticus - A systematic review.
Dibué-Adjei M; Brigo F; Yamamoto T; Vonck K; Trinka E
Brain Stimul; 2019; 12(5):1101-1110. PubMed ID: 31126871
[TBL] [Abstract][Full Text] [Related]
16. Use of Newer Anticonvulsants for the Treatment of Status Epilepticus.
Farrokh S; Bon J; Erdman M; Tesoro E
Pharmacotherapy; 2019 Mar; 39(3):297-316. PubMed ID: 30723940
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of ketamine in the treatment of refractory and super-refractory status epilepticus in children].
Wu J; Wang Q; Qian SY; Gao HM; Liu J; Deng J; Zeng JS
Zhonghua Er Ke Za Zhi; 2020 Apr; 58(4):295-300. PubMed ID: 32234136
[No Abstract] [Full Text] [Related]
18. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
Dubey D; Bhoi SK; Kalita J; Misra UK
Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
[TBL] [Abstract][Full Text] [Related]
19. Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus.
Rao SK; Mahulikar A; Ibrahim M; Shah A; Seraji-Bozorgzad N; Mohamed W
Epileptic Disord; 2018 Aug; 20(4):265-269. PubMed ID: 30113012
[TBL] [Abstract][Full Text] [Related]
20. How much refractory is 'refractory status epilepticus'? A retrospective study of treatment strategies and clinical outcomes.
Lattanzi S; Giovannini G; Orlandi N; Brigo F; Trinka E; Meletti S
J Neurol; 2023 Dec; 270(12):6133-6140. PubMed ID: 37587268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
